---
title: "301093.SZ (301093.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301093.SZ/news.md"
symbol: "301093.SZ"
name: "301093.SZ"
parent: "https://longbridge.com/en/quote/301093.SZ.md"
datetime: "2026-05-20T14:24:43.661Z"
locales:
  - [en](https://longbridge.com/en/quote/301093.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301093.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301093.SZ/news.md)
---

# 301093.SZ (301093.SZ) — Related News

### [HUALAN NPM and others establish a smart technology company](https://longbridge.com/en/news/285875072.md)
*2026-05-11T03:21:17.000Z*
> HUALAN NPM's wholly-owned subsidiary Hainan Lingqing Smart Pharmaceutical Technology Co., Ltd. has jointly established S

### [HUALAN NPM: 2025 net profit growth of 21%, core business stable, AI pharmaceuticals open a second growth curve](https://longbridge.com/en/news/283855566.md)
*2026-04-23T14:38:33.000Z*
> On the evening of April 23, HUALAN NPM released its annual report for 2025 and the quarterly report for the first quarte

### [HUALAN NPM: Net profit of RMB 609,600 in the first quarter of 2026, a year-on-year decrease of 96.68%](https://longbridge.com/en/news/283828383.md)
*2026-04-23T12:08:31.000Z*
> HUALAN NPM announced that in the first quarter of 2026, the operating revenue was 130 million yuan, a year-on-year decre

### [HUALAN NPM: 50 million yuan investment to increase AI pharmaceutical development, building a new drug research and development platform that integrates AI with physical constraints](https://longbridge.com/en/news/283372344.md)
*2026-04-20T14:43:37.000Z*
> On April 20th, HUALAN NPM announced that its wholly-owned subsidiary Hainan Lingqing Smart Pharmaceutical Technology Co.

### [HUALAN NPM: Wholly-owned subsidiary plans to invest 50 million yuan to establish a wholly-owned subsidiary](https://longbridge.com/en/news/283328890.md)
*2026-04-20T09:50:20.000Z*
> HUALAN NPM announced that its wholly-owned subsidiary, Hainan Lingqing Smart Pharmaceutical Technology Co., Ltd., plans 

### [HUALAN NPM strategically invests in Jiawu Yi, further improving the integrated AI pharmaceutical ecosystem](https://longbridge.com/en/news/283258751.md)
*2026-04-19T15:18:41.000Z*
> On April 19th, Jiawu Yi (Beijing) Technology Co., Ltd. officially disclosed through its official public account that HUA

### [](https://longbridge.com/en/news/281819626.md)
*2026-04-07T02:16:54.000Z*
> The A-share medical consumables concept experienced fluctuations and surged during the trading session, with INTCO risin

### [HUALAN NPM plans to sell 61.4% equity of Tibet Hualan to Hualan Import and Export](https://longbridge.com/en/news/279941995.md)
*2026-03-20T12:23:13.000Z*
> HUALAN NPM signed a share transfer agreement with Jiangsu HUALAN Import and Export Co., Ltd., intending to transfer its 

### [](https://longbridge.com/en/news/279520826.md)
*2026-03-18T02:25:11.000Z*
> The A-share innovative drug sector fluctuated upward, with HUALAN NPM and Rongchang Bio reaching intraday highs, VCANBIO